Microport Cardioflow Medtech Corp
Microport Cardioflow Medtech's GHG Emissions Data Preview
In 2023, Microport Cardioflow Medtech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Microport Cardioflow Medtech has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Microport Cardioflow Medtech's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Microport Cardioflow Medtech amounted to 3,345.9 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Microport Cardioflow Medtech decreased by 39.25%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Microport Cardioflow Medtech's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Microport Cardioflow Medtech's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Microport Cardioflow Medtech were 267.5 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Microport Cardioflow Medtech reduced its Scope 1 emissions over time?
Since 2020, Microport Cardioflow Medtech's Scope 1 emissions have increased by 5,702.6%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Microport Cardioflow Medtech's Scope 1 emissions decreased by 23.22%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Microport Cardioflow Medtech's Scope 2 emissions?
In 2023, Microport Cardioflow Medtech reported Scope 2 greenhouse gas (GHG) emissions of 3,078.4 tCOâ‚‚e without specifying the calculation method.
Has Microport Cardioflow Medtech reduced its Scope 2 emissions over time?
Since 2020, Microport Cardioflow Medtech's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 23.83%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Microport Cardioflow Medtech's Scope 2 emissions (Unspecified Calculation Method) fell by 40.34% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
What methodology does Microport Cardioflow Medtech use for Scope 2 reporting?
In 2023, Microport Cardioflow Medtech reported its Scope 2 emissions using an unspecified methodology.
Microport Cardioflow Medtech's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)